Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Berquist Ii

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPharmacology & Toxicology, College of Medicine
DivisionPharmacology Research
Address4104 Outpatient Circle
Mail Slot # 611
Little Rock AR 72205
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    1U01DA056240     (GENTRY, WILLIAM B)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    1U01DA056240-01     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    5U01DA056240     (GENTRY, WILLIAM B)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    5U01DA056240-02     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    5U01DA056240-03     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Tobacyk J, Parks BJ, Salazar P, Coward LU, Berquist MD, Gorman GS, Brents LK. Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. Drug Alcohol Depend. 2023 08 01; 249:110832. PMID: 37385117.
      View in: PubMed
    2. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Johnson JW, Holloway KN, Berquist MD, Kane CJM, Drew PD. Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation. Am J Drug Alcohol Abuse. 2023 05 04; 49(3):345-358. PMID: 36345683.
      View in: PubMed
    3. Berquist MD, Fantegrossi WE. Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats. Behav Pharmacol. 2021 08 01; 32(5):382-391. PMID: 33595958.
      View in: PubMed
    4. Findley DL, Berquist MD, Hambuchen MD. Methamphetamine-Induced Open Field Behavior and LD50 in Periplaneta americana Cockroaches (Blattodea: Blattidae). J Econ Entomol. 2021 02 09; 114(1):476-480. PMID: 33146384.
      View in: PubMed
    5. Berquist MD, McGill MR, Mazur A, Findley DL, Gorman G, Jones CB, Hambuchen MD. Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats. Drug Alcohol Depend. 2020 10 01; 215:108190. PMID: 32736295.
      View in: PubMed
    6. Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Drug Alcohol Depend. 2020 03 01; 208:107850. PMID: 31954950.
      View in: PubMed
    7. Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization. Psychopharmacology (Berl). 2020 Feb; 237(2):431-442. PMID: 31729537.
      View in: PubMed
    8. Hyatt WS, Berquist MD, Chitre NM, Russell LN, Rice KC, Murnane KS, Fantegrossi WE. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats. Behav Pharmacol. 2019 10; 30(7):555-565. PMID: 31211703.
      View in: PubMed
    9. McClenahan SJ, Hambuchen MD, Simecka CM, Gunnell MG, Berquist MD, Owens SM. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug Alcohol Depend. 2019 02 01; 195:140-147. PMID: 30634109.
      View in: PubMed
    10. Hambuchen MD, Berquist MD, Simecka CM, McGill MR, Gunnell MG, Hendrickson HP, Owens SM. Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats. J Pharm Pharm Sci. 2019; 22(1):301-312. PMID: 31329536.
      View in: PubMed
    11. Fantegrossi WE, Wilson CD, Berquist MD. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug Metab Rev. 2018 Feb; 50(1):65-73. PMID: 29385930.
      View in: PubMed
    12. Berquist MD, Fantegrossi WE. Discriminative Stimulus Effects of Psychostimulants. Curr Top Behav Neurosci. 2018; 39:29-49. PMID: 28341944.
      View in: PubMed
    13. Ford BM, Franks LN, Tai S, Fantegrossi WE, Stahl EL, Berquist MD, Cabanlong CV, Wilson CD, Penthala NR, Crooks PA, Prather PL. Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development. Pharmacol Res. 2017 Nov; 125(Pt B):161-177. PMID: 28838808.
      View in: PubMed
    14. Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE. Phencyclidine-like in?vivo effects of methoxetamine in mice and rats. Neuropharmacology. 2018 05 15; 134(Pt A):158-166. PMID: 28830759.
      View in: PubMed
    15. Hambuchen MD, Hendrickson HP, Gunnell MG, McClenahan SJ, Ewing LE, Gibson DM, Berquist MD, Owens SM. The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug Alcohol Depend. 2017 10 01; 179:347-354. PMID: 28844011.
      View in: PubMed
    Berquist Ii's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (89) concept(s)
    _
    Co-Authors Expand Description
    See all (10) people
    _
    Similar People Expand Description
    See all (27) people
    _
    Same Department Expand Description
    Search Department